Effects of Short-term Therapeutic Fasting on Nausea and Vomiting Due to Chemotherapy

Launched by CENTRE HOSPITALIER UNIVERSITAIRE DE LA RÉUNION · Oct 24, 2019

Keywords

ClinConnect Summary

This clinical trial is studying how short-term partial fasting may help reduce nausea and vomiting in patients undergoing certain types of chemotherapy. Specifically, it looks at patients who are starting treatment with the ABVD or AVD chemotherapy regimens, which are known to cause significant nausea. The goal is to see if fasting for a short period can make a difference in how these patients feel in the days following their chemotherapy sessions.

To participate in this study, patients need to be starting treatment with one of the specified chemotherapy protocols and be part of a social security scheme. They must also provide their informed consent, meaning they understand the study and agree to join. However, some patients may not be eligible, such as those with diabetes, recent gastric ulcers, or significant weight loss. If you decide to join, you can expect to follow a specific fasting routine and share your experiences regarding nausea and vomiting after your chemotherapy sessions. This research could help improve care for future patients facing similar challenges.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • patient starting a treatment by chemotherapy ABVD or AVD
• • patient affiliated to a social security scheme
• • patient who gives his informed consent before any procedure related to the study
• Exclusion Criteria:
• • patient with diabetes
• • patient with recent gastric ulcer
• • patient with low BMI (less than 18,5 for patients under 70 or less than 21 for patient over 70)
• • albuminemia \<35
• • patient wiht loss weight \> 10% in 6 months
• • pregnant or lactating women
• • chronic alcoholism
• • unable to understand the objectives and risks of the study
• • patient with psychiatric desorder, under guardianship or under judicial protection
• • patient who cannot read